Zenotech Laboratories LimitedBSE: ZENOTECH

Zenotech Laboratories - Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024 And Appointment Of Dr. Sachin Laxmanappa Gavandare As Chief Executive Officer (Key Managerial Personnel) Of The Compa

· Issued by Zenotech Laboratories Limited via BSE India

Filed with BSE ·

On 6ix: 6ix.com/news/zenotech-laboratories-board-meeting-outcome-for-unaudited-financial-results-for-the-quarter-and-half-year-ended-september-30-2024-and-appointment-of-dr-sachin-laxmanappa-gavandare-as-chief-executive-officer-key-managerial-personnel-of-the-compa

Unaudited Financial Results for the quarter and half year ended September 30, 2024 and appointment of Dr. Sachin Laxmanappa Gavandare as Chief Executive Officer (Key Managerial Personnel) of the Company with immediate effect.

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Zenotech Laboratories Limited on 6ix

Later from Zenotech Laboratories

All Zenotech Laboratories news releases